Hospital de Mataró-ko ikertzaileekin lankidetzan egindako argitalpenak (15)

2023

  1. Cognitive and clinical gender-related differences among binge-spectrum eating disorders: Analysis of therapy response predictors

    European Eating Disorders Review, Vol. 31, Núm. 3, pp. 377-389

  2. Craving in gambling disorder: A systematic review

    Journal of Behavioral Addictions

  3. Do the negative symptoms of schizophrenia reflect reduced responsiveness to reward? Examination using a reward prediction error (RPE) task

    Psychological Medicine, Vol. 20

  4. Improved estimation of the risk of manic relapse by combining clinical and brain scan data

    Revista de Psiquiatria y Salud Mental

  5. Neural correlates of referential/persecutory delusions in schizophrenia: Examination using fMRI and a virtual reality underground travel paradigm

    Psychological Medicine, Vol. 53, Núm. 10, pp. 4780-4787

2022

  1. Clusters of inflammation in COVID-19: descriptive analysis and prognosis on more than 15,000 patients from the Spanish SEMI-COVID-19 Registry

    Internal and Emergency Medicine, Vol. 17, Núm. 4, pp. 1115-1127

  2. Does admission acetylsalicylic acid uptake in hospitalized COVID-19 patients have a protective role? Data from the Spanish SEMI-COVID-19 Registry

    Internal and Emergency Medicine, Vol. 17, Núm. 3, pp. 761-775

  3. Negative schizophrenic symptoms as prefrontal cortex dysfunction: Examination using a task measuring goal neglect

    NeuroImage: Clinical, Vol. 35

2017

  1. Myths and evidence on the use of botulinum toxin: Spasticity in adults and in children with cerebral palsy

    Revista de Neurologia, Vol. 64, Núm. 10, pp. 459-470

2015

  1. Dolutegravir for the treatment of HIV-2 infection

    Journal of Clinical Virology, Vol. 64, pp. 12-15

2014

  1. Causas que justifican el cambio del tratamiento antirretroviral en personas con infección por el VIH en España (años 2010-2011). Estudio SWITCH AUDIT

    Revista Espanola de Quimioterapia, Vol. 27, Núm. 2, pp. 93-97

  2. Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries

    AIDS, Vol. 28, Núm. 16, pp. 2461-2473

2010

  1. Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per μl in Europe and North America: A pooled cohort observational study

    The Lancet, Vol. 376, Núm. 9738, pp. 340-345

2009

  1. Variable Impact on Mortality of AIDS-Defining Events Diagnosed during Combination Antiretroviral Therapy: Not All AIDS-Defining Conditions Are Created Equal

    Clinical Infectious Diseases, Vol. 48, Núm. 8, pp. 1138-1151

2007

  1. Infection by the type 2 human immunodeficiency virus and types 1 and 2 human lymphotropic virus in Spain

    Medicina Clinica